Values as of: 2024-11-13
COMMON STOCK | Tobacco |
Last Closing
USD 55Change
0.00 (0.00)%Market Cap
USD 0.91BVolume
0.17MAnalyst Target
USD 41.75Verdict
Verdict
Turning Point Brands, Inc., together with its subsidiaries, manufactures, markets, and distributes branded consumer products. The company operates through three segments: Zig-Zag Products, Stoker's Products, and Creative Distribution Solutions. Zig-Zag Products segment markets and distributes rolling papers, tubes, finished cigars, make-your-own cigar wraps, and related products, as well as lighters and other accessories under the Zig-Zag brand. The Stoker's Products segment manufactures and markets moist snuff tobacco and loose-leaf chewing tobacco products under the Stoker's, Beech-Nut, Durango, Trophy, and Wind River brands. Its Creative Distribution Solutions segment market and distribute other products without tobacco and/or nicotine to individual consumers through VaporFi B2C online platform, as well as non-traditional retail through VaporBeast. In addition, it markets and distributes cannabis accessories and tobacco products. The company sells its products to wholesale distributors and retail merchants in the independent and chain convenience stores, tobacco outlets, food stores, mass merchandising, drug store, and non-traditional retail channels. The company was formerly known as North Atlantic Holding Company, Inc. and changed its name to Turning Point Brands, Inc. in November 2015. Turning Point Brands, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky.
Company Website : https://www.turningpointbrands.com/home/default.as
Currency: USD
Country : USA
| Symbol | Name | Price(Change) | Market Cap |
|---|---|---|---|
| BTI | British American Tobacco p.l.c.. |
+0.18 (+0.51%) |
USD 77.39B |
| RLX | RLX Technology Inc |
+0.02 (+1.26%) |
USD 2.54B |
| MO | Altria Group |
+0.81 (+1.49%) |
N/A |
| PM | Philip Morris International In.. |
+1.02 (+0.82%) |
N/A |
| UVV | Universal Corporation |
+0.74 (+1.40%) |
N/A |
| Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
|---|---|---|---|---|---|
| CBDX:SW | 14.55 % | 0.00 % |
N/A |
N/A | |
| CBDP:LSE | 14.48 % | 0.00 % |
N/A |
N/A | |
| VICE | AdvisorShares Vice ETF | 9.02 % | 0.00 % |
-0.12 (0%) |
USD 7.08M |
| EQWS | 0.00 % | 0.25 % |
N/A |
N/A | |
| ACT | Enact Holdings Inc | 0.00 % | 0.75 % |
-0.32 (0%) |
USD 5.32B |
| WMCR | 0.00 % | 0.50 % |
N/A |
N/A | |
| MJX | 0.00 % | 0.00 % |
N/A |
N/A | |
| CBDX:LSE | 0.00 % | 0.00 % |
N/A |
N/A | |
| CBSX:XETRA | 0.00 % | 0.00 % |
N/A |
N/A | |
| CBSX:F | 0.00 % | 0.00 % |
N/A |
N/A |
| Market Performance vs. Industry/Classification (Tobacco) | Market Performance vs. Exchange | ||||||
| Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
| YTD | |||||||
| Capital Gain | 108.97% | 100% | F | 98% | N/A | ||
| Dividend Return | 0.80% | 20% | F | 11% | F | ||
| Total Return | 109.76% | 100% | F | 98% | N/A | ||
| Trailing 12 Months | |||||||
| Capital Gain | 140.59% | 100% | F | 97% | N/A | ||
| Dividend Return | 1.20% | 20% | F | 14% | F | ||
| Total Return | 141.80% | 100% | F | 97% | N/A | ||
| Trailing 5 Years | |||||||
| Capital Gain | 107.94% | 100% | F | 86% | B+ | ||
| Dividend Return | 4.44% | 20% | F | 11% | F | ||
| Total Return | 112.38% | 100% | F | 85% | B | ||
| Average Annual (5 Year Horizon) | |||||||
| Capital Gain | 16.86% | 100% | F | 78% | C+ | ||
| Dividend Return | 17.52% | 100% | F | 77% | C+ | ||
| Total Return | 0.66% | 20% | F | 16% | F | ||
| Risk Return Profile | |||||||
| Volatility (Standard Deviation) | 55.95% | 17% | F | 17% | F | ||
| Risk Adjusted Return | 31.32% | 50% | F | 48% | F | ||
| Market Capitalization | 0.91B | 33% | F | 56% | F | ||
| Target Price Action | Rating Action | Analyst | Rating | Price | Date |
|---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The company has under performed its peers on annual average total returns in the past 5 years.
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
